Privia Health Group Inc (PRVA) PT Lowered to $28 at Truist Securities

Truist Securities analyst Jailendra Singh lowered the price target on Privia Health Group Inc (NASDAQ: PRVA) to $28.00 (from $32.00) while maintaining a Buy rating.

The analyst comments "We had a post quarterly conference call with PRVA management to discuss its 4Q23 results, 2024 outlook, views on capitation, etc. The answers are not verbatim, but we put the company’s answers in their proper context in a give and take format. With this note, we are updating our PT to $28 (previously $32)."

You May Also Be Interested In

• Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$236 at Bernstein SocGen Group
• J.B. Hunt Transport Services (JBHT) PT Lowered to $264 at UBS on Cost Pressures
• Amgen (AMGN) PT Lowered to $430 at UBS